Clomipramine

Verify with FDA CVM →

693 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
693
Total Reports
12
Deaths Reported
170.0%
Death Rate

Active Ingredients

Clomipramine

Administration Routes

OralUnknownRespiratory (Inhalation)

Species Affected

Dog 353
Unknown 281
Cat 31
Human 28

Most Affected Breeds

Unknown 310
Crossbred Canine/dog 39
Retriever - Labrador 30
Shih Tzu 15
Domestic Shorthair 13
Shepherd Dog - German 13
Pit Bull 12
Retriever - Golden 12
Terrier - Yorkshire 11
Beagle 11

Most Reported Reactions

Tablets, Abnormal 252
Uncoded sign 209
Lack of efficacy - NOS 81
Vomiting 68
Lethargy (see also Central nervous system depression in 'Neurological') 45
Diarrhoea 40
Behavioural disorder NOS 33
Accidental exposure 32
Elevated alanine aminotransferase (ALT) 30
Elevated serum alkaline phosphatase (SAP) 28
Other abnormal test result NOS 27
Weight loss 26

Outcome Breakdown

Outcome Unknown
126 (38.8%)
Recovered/Normal
93 (28.6%)
Ongoing
88 (27.1%)
Died
8 (2.5%)
Recovered with Sequela
6 (1.8%)
Euthanized
4 (1.2%)

Data Summary

Metric Value
Total adverse event reports 693
Reports involving death 12
Case-fatality rate (reported events) 170.0%
Distinct species in reports 4
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Clomipramine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 693 adverse event reports referencing Clomipramine, including 12 reports in which the animal died — a 170.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Clomipramine. Reported administration routes include Oral, Unknown, Respiratory (Inhalation). These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Clomipramine reports are Dog (353 reports), Unknown (281 reports), Cat (31 reports), with Dog accounting for the largest share. Within those species, Unknown (310), Crossbred Canine/dog (39), Retriever - Labrador (30) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Clomipramine are Tablets, Abnormal (252), Uncoded sign (209), Lack of efficacy - NOS (81), Vomiting (68). Of the 325 reports with a coded outcome, Outcome Unknown is the leading category at 38.8%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Clomipramine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial